Farallon Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $165M | Buy |
|
|||||
|
2023
Q3 | $372K | Hold |
|
|||||
|
2023
Q2 | $477K | Hold |
|
|||||
|
2023
Q1 | $400K | Hold |
|
|||||
|
2022
Q4 | $432K | Sell |
|
|||||
|
2022
Q3 | $18M | Sell |
|
|||||
|
2022
Q2 | $12.7M | Sell |
|
|||||
|
2022
Q1 | $44.4M | Sell |
|
|||||
|
2021
Q4 | $72M | Sell |
|
|||||
|
2021
Q3 | $85.6M | Buy |
|
|||||
|
2021
Q2 | $71.8M | Sell |
|
|||||
|
2021
Q1 | $81.2M | Sell |
|
|||||
|
2020
Q4 | $71.1M | Hold |
|
|||||
|
2020
Q3 | $54.1M | Buy |
|
|||||
|
2020
Q2 | $64.1M | Buy |
|
|||||
|
2020
Q1 | $40.8M | Sell |
|
|||||
|
2019
Q4 | $45.2M | Buy |
|